Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jiangxi Boen Ruier Biotechnology is a high-tech enterprise specializing in the research, development, and manufacturing of advanced regenerative medical materials and high-end surgical consumables. Founded in 2013 and headquartered in Nanchang, China, the company focuses on tissue engineering and bio-active materials to address clinical needs in wound care, hemostasis, and bone repair. Its product portfolio includes absorbable hemostatic materials, medical adhesives, and surgical sealants that utilize proprietary hydrogel and polymer technologies. Boen Ruier has established a strong presence in the Chinese market with multiple NMPA-approved products and continues to expand its pipeline into complex tissue regeneration and clinical aesthetics. The company is backed by prominent venture capital firms including Qiming Venture Partners and Legend Capital.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jiangxi Boen Ruier Biotechnology.